trial · primary record
ADT
Prostate Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
| Registry ID | NCT05873192 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:03.799Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05873192
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.